[1]Savini I, Catani MV, Evangelista D, et al. Obesity-associated oxidative stress: strategies finalized to improve redox state[J]. Int J Mol Sci, 2013,14(5):10497-10538.
[2]Oh JH, Kim J, Lee Y. Anti-inflammatory and anti-diabetic effects of brown seaweeds in high-fat diet-induced obese mice[J]. Nutr Res Pract, 2016,10(1):42-48.
[3]Haase J, Weyer U, Immig K, et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation[J]. Diabetologia, 2014,57(3):562-571.
[4]Fan N, Sun H, Wang Y, et al. Follistatin-like 1: a potential mediator of inflammation in obesity[J]. Mediators Inflamm, 2013,2013:752519.
[5]Chaly Y, Hostager B, Smith S, et al. Follistatin-like protein 1 and its role in inflammation and inflammatory diseases[J]. Immunol Res, 2014,59(1-3):266-572.
[6]Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention[J]. Ann Nutr Metab, 2015,66 (Suppl 2):7-12.
[7]Goldlust IS, Hermetz KE, Catalano LM, et al. Mouse model implicates GNB3 duplication in a childhood obesity syndrome[J]. Proc Natl Acad Sci USA, 2013, 110(37):14990-14994.
[8]Wan M, Easton RM, Gleason CE, et al. Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity[J]. Mol Cell Biol, 2012,32(1):96-106.
[9]Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity therapy[J]. Nat Rev Drug discov, 2010, 9(6):465-482.
[10]Palou A, Bonet ML. Challenges in obesity research[J]. Nutr Hosp, 2013,28 (Suppl 5):144-153.
[11]Lee YH, Mottillo EP, Granneman JG. Adipose tissue plasticity from WAT to BAT and in between[J]. Biochim Biophysi Acta, 2014,1842(3):358-369.
[12]Seale P, Conroe HM, Estall J, et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice[J]. J Clin Invest, 2011,121(1):96-105.
[13]Meng XZh, Zheng RP, Zhang Y, et al. Comparison of glucose and lipid metabolism in two types of Parkinson s disease rat models[J]. Acta Anatomica Sinica, 2014, 45 (5): 605-609. (in chinese)
孟祥志, 郑瑞攀, 张迎, 等. 两种帕金森病大鼠糖脂代谢模型的比较[J]. 解剖学报,2014,45 (5):605-609.
[14]Després J, Lemieux S, Lamarche B, et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications[J]. Int J Obes Relat Metab Disord, 1995, 19 (Suppl 1):S76-86.
[15]Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study[J]. Circulation, 2007, 116(1):39-48.
[16]Murano I, Barbatelli G, Parisani V, et al, Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice[J]. J Lipid Res, 2008, 49(7):1562-1568.
[17]Wang Y, Li D, Xu N, et al. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis[J]. Arthritis Res Ther, 2011,13(6):R193.
[18]Sylva M, Moorman AF, van den Hoff MJ. Follistatin-like 1 in vertebrate development[J]. Birth defects Res C Embryo today, 2013,99(1):61-69.
[19]Li D, Wang Y, Xu N, et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis[J]. Arthritis Res Ther, 2011,13(1):R17.
[20]Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance[J]. Science (New York, NY),1993,259(5091):87-91.
[21]Schulz TJ, Tseng YH. Brown adipose tissue: development, metabolism and beyond[J]. Biochem J, 2013,453(2):167-178.
[22]Wankhade UD, Shen M, Yadav H, et al. Novel Browning Agents, Mechanisms, and Therapeutic Potentials of Brown Adipose Tissue[J]. BioMed Res Int, 2016,2016:2365609.
|